Somatic mutation correlation with lymph node metastasis and prognosis in T1/2 stage colorectal cancer patients: A propensity score matching analysis

Junwei Tang; Yue Zhang; Dongjian Ji; Lu Wang; Han Zhuo; Yaping Wang; Yueming Sun

doi:10.1002/ctm2.70179

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (1) : e70179 DOI: 10.1002/ctm2.70179

LETTER TO THE JOURNAL

Somatic mutation correlation with lymph node metastasis and prognosis in T1/2 stage colorectal cancer patients: A propensity score matching analysis

Author information +

History +

PDF

Cite this article

Download citation ▾

Junwei Tang, Yue Zhang, Dongjian Ji, Lu Wang, Han Zhuo, Yaping Wang, Yueming Sun. Somatic mutation correlation with lymph node metastasis and prognosis in T1/2 stage colorectal cancer patients: A propensity score matching analysis. Clinical and Translational Medicine, 2025, 15(1): e70179 DOI:10.1002/ctm2.70179

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Inadomi J, Jung B. Colorectal cancer-recent advances and future challenges. Gastroenterology. 2020;158(2):289-290.

[2]	Shen X, DeWan AT, Johnson CH. Early-onset colorectal cancer somatic gene mutations by population subgroups. Cancer Discov. 2023;13(3):530-531.

[3]	Mo S, Zhou Z, Dai W, et al. Development and external validation of a predictive scoring system associated with metastasis of T1-2 colorectal tumors to lymph nodes. Clin Transl Med. 2020;10(1):275-287.

[4]	Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol. 2001;19(4):1128-1136.

[5]	Wada Y, Shimada M, Murano T, et al. A liquid biopsy assay for noninvasive identification of lymph node metastases in T1 colorectal cancer. Gastroenterology. 2021;161(1):151-162. e151.

[6]	Ciombor KK, Strickler JH, Bekaii-Saab TS, Yaeger R. BRAF-mutated advanced colorectal cancer: a rapidly changing therapeutic landscape. J Clin Oncol. 2022;40(24):2706-2715.

[7]	Tapia-Valladares C, Valenzuela G, Gonzalez E, et al. Distinct driver pathway enrichments and a high prevalence of TSC2 mutations in right colon cancer in Chile: a preliminary comparative analysis. Int J Mol Sci. 2024;25(9):4695.

[8]	Yang Z, Li C, Fan Z, et al. Single-cell sequencing reveals variants in ARID1A, GPRC5A and MLL2 driving self-renewal of human bladder cancer stem cells. Eur Urol. 2017;71(1):8-12.

[9]	Ge W, Hu H, Cai W, et al. High-risk stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment. Int J Cancer. 2020;146(7):2027-2035.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.